Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 1
2015 1
2017 1
2020 6
2021 6
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
An encapsulated bulky abdominal abscess due to amoeba.
Iritani S, Kawamura Y, Yamashige D, Muraishi N, Kajiwara A, Fujiyama S, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Kobayashi M, Saitoh S, Suzuki F, Arase Y, Ikeda K, Suzuki Y, Kumada H. Iritani S, et al. Clin J Gastroenterol. 2021 Apr;14(2):555-559. doi: 10.1007/s12328-020-01331-0. Epub 2021 Jan 11. Clin J Gastroenterol. 2021. PMID: 33428067
Effects of alcohol consumption on multiple hepatocarcinogenesis in patients with fatty liver disease.
Ochiai Y, Kawamura Y, Kobayashi M, Shindoh J, Kobayashi Y, Okubo S, Muraishi N, Kajiwara A, Iritani S, Fujiyama S, Hosaka T, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Ikeda K, Arase Y, Hashimoto M, Kumada H. Ochiai Y, et al. Among authors: iritani s. Hepatol Res. 2021 Jan;51(1):62-68. doi: 10.1111/hepr.13572. Epub 2020 Oct 1. Hepatol Res. 2021. PMID: 32939922
Efficacy and Safety of Ramucirumab in Patients with Unresectable Hepatocellular Carcinoma with Progression after Treatment with Lenvatinib.
Kasuya K, Kawamura Y, Kobayashi M, Shindoh J, Kobayashi Y, Kajiwara A, Iritani S, Fujiyama S, Hosaka T, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Ikeda K, Arase Y, Eguchi Y, Hashimoto M, Kumada H. Kasuya K, et al. Among authors: iritani s. Intern Med. 2021 Feb 1;60(3):345-351. doi: 10.2169/internalmedicine.5185-20. Epub 2020 Sep 19. Intern Med. 2021. PMID: 32963154 Free PMC article.
Potential and Clinical Significance of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment.
Yamashige D, Kawamura Y, Kobayashi M, Shindoh J, Kobayashi Y, Okubo S, Muraishi N, Kajiwara A, Iritani S, Fujiyama S, Hosaka T, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Ikeda K, Arase Y, Hashimoto M, Kumada H. Yamashige D, et al. Among authors: iritani s. Oncology. 2021;99(3):169-176. doi: 10.1159/000510754. Epub 2020 Nov 18. Oncology. 2021. PMID: 33207358 Free PMC article.
Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma.
Kawamura Y, Kobayashi M, Shindoh J, Kobayashi Y, Okubo S, Tominaga L, Kajiwara A, Kasuya K, Iritani S, Fujiyama S, Hosaka T, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Ikeda K, Arase Y, Hashimoto M, Kozuka T, Kumada H. Kawamura Y, et al. Among authors: iritani s. Liver Cancer. 2020 Dec;9(6):756-770. doi: 10.1159/000510299. Epub 2020 Oct 30. Liver Cancer. 2020. PMID: 33442544 Free PMC article.
Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Overall Prognosis Following Lenvatinib Treatment.
Kawamura Y, Kobayashi M, Shindoh J, Kobayashi Y, Okubo S, Muraishi N, Iritani S, Fujiyama S, Hosaka T, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Ikeda K, Arase Y, Hashimoto M, Kumada H. Kawamura Y, et al. Among authors: iritani s. Oncology. 2021;99(10):611-621. doi: 10.1159/000516565. Epub 2021 Jun 17. Oncology. 2021. PMID: 34139691 Free article.
Changes in the Mean Intrahepatic Target Computed Tomography Attenuation Value During Treatment May be a Useful New Predictor of the Post-progression Survival Associated with Lenvatinib Treatment.
Muraishi N, Kawamura Y, Kobayashi M, Shindoh J, Kobayashi Y, Okubo S, Iritani S, Fujiyama S, Hosaka T, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Ikeda K, Arase Y, Hashimoto M, Yasuda I, Kumada H. Muraishi N, et al. Among authors: iritani s. Intern Med. 2021 Sep 11. doi: 10.2169/internalmedicine.7589-21. Online ahead of print. Intern Med. 2021. PMID: 34511564 Free article.
12 results